TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...

AstraZeneca PLC AZN and its Japan-based partner Daiichi Sankyo announced that the FDA has approved their blockbuster antibody-drug conjugate (ADC), Enhertu, for first-line use in breast cancer.

Repurposing traditional professional learning communities as teacher-led teams builds trust and strengthens instructional alignment.

Centessa Pharmaceuticals plc (NASDAQ:CNTA) is one of the best 52-week high stocks to buy right now. On December 1, B. Riley ...

A private B.C. college has shuttered its doors after provincial inspectors found the school misled international students ...

LUMRYZ is only currently approved for the treatment of cataplexy or EDS in patients seven years of age and older with narcolepsy, and Avadel does not market, promote or offer patient support services ...

In a statement on the same day, Tronox Holdings plc (NYSE:TROX) said that it earned the financial backing of the Export Finance Australia (EFA) and the Export-Import Bank of the United States (EXIM) ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...

PureTech Health PLC (NASDAQ:PRTC) dropped 8.1% in Monday’s premarket trading after providing an update on its End-of-Phase 2 discussions with the FDA regarding deupirfenidone, a potential treatment ...

Chemring Group PLC ( CMGMY) Q4 2025 Earnings Call December 9, 2025 4:00 AM EST ...